Literature DB >> 27067316

Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae.

Yi-Hsiang Cheng1, Tzu-Lung Lin1, Yi-Tsung Lin2, Jin-Town Wang3.   

Abstract

Colistin is a last-resort antibiotic for treatment of carbapenem-resistant Klebsiella pneumoniae A recent study indicated that missense mutations in the CrrB protein contribute to colistin resistance. In our previous study, mechanisms of colistin resistance were defined in 17 of 26 colistin-resistant K. pneumoniae clinical isolates. Of the remaining nine strains, eight were highly resistant to colistin. In the present study, crrAB sequences were determined for these eight strains. Six separate amino acid substitutions in CrrB (Q10L, Y31H, W140R, N141I, P151S, and S195N) were detected. Site-directed mutagenesis was used to generate crrB loci harboring individual missense mutations; introduction of the mutated genes into a susceptible strain, A4528, resulted in 64- to 1,024-fold increases in colistin MICs. These crrB mutants showed increased accumulation of H239_3062, H239_3059, pmrA, pmrC, and pmrH transcripts by quantitative reverse transcription (qRT)-PCR. Deletion of H239_3062 (but not that of H239_3059) in the A4528 crrB(N141I) strain attenuated resistance to colistin, and H239_3062 was accordingly named crrC Similarly, accumulation of pmrA, pmrC, and pmrH transcripts induced by crrB(N141I) was significantly attenuated upon deletion of crrC Complementation of crrC restored resistance to colistin and accumulation of pmrA, pmrC, and pmrH transcripts in a crrB(N141I) ΔcrrC strain. In conclusion, novel individual CrrB amino acid substitutions (Y31H, W140R, N141I, P151S, and S195N) were shown to be responsible for colistin resistance. We hypothesize that CrrB mutations induce CrrC expression, thereby inducing elevated expression of the pmrHFIJKLM operon and pmrC (an effect mediated via the PmrAB two-component system) and yielding increased colistin resistance.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27067316      PMCID: PMC4879426          DOI: 10.1128/AAC.00009-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.

Authors:  Matthew E Falagas; Sofia Maraki; Drosos E Karageorgopoulos; Antonia C Kastoris; Emmanuel Mavromanolakis; George Samonis
Journal:  Int J Antimicrob Agents       Date:  2010-03       Impact factor: 5.283

2.  In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.

Authors:  Antonio Cannatelli; Vincenzo Di Pilato; Tommaso Giani; Fabio Arena; Simone Ambretti; Paolo Gaibani; Marco Maria D'Andrea; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

Review 3.  Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Authors:  Neil Gupta; Brandi M Limbago; Jean B Patel; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

4.  PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.

Authors:  Amanda K Miller; Mark K Brannon; Laurel Stevens; Helle Krogh Johansen; Sara E Selgrade; Samuel I Miller; Niels Høiby; Samuel M Moskowitz
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

Review 5.  Colistin, mechanisms and prevalence of resistance.

Authors:  Abed Zahedi Bialvaei; Hossein Samadi Kafil
Journal:  Curr Med Res Opin       Date:  2015-03-19       Impact factor: 2.580

6.  The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica.

Authors:  Hyunwoo Lee; Fong-Fu Hsu; John Turk; Eduardo A Groisman
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

7.  SMART: recent updates, new developments and status in 2015.

Authors:  Ivica Letunic; Tobias Doerks; Peer Bork
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

8.  Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide.

Authors:  Andrew M Lippa; Mark Goulian
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917

9.  National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.

Authors:  Sheng-Kang Chiu; Tsu-Lan Wu; Yin-Ching Chuang; Jung-Chung Lin; Chang-Phone Fung; Po-Liang Lu; Jann-Tay Wang; Lih-Shinn Wang; L Kristopher Siu; Kuo-Ming Yeh
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Prediction of membrane transport proteins and their substrate specificities using primary sequence information.

Authors:  Nitish K Mishra; Junil Chang; Patrick X Zhao
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more
  36 in total

Review 1.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

2.  Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and crrB Mutation-Mediated Colistin Resistance.

Authors:  Lang Sun; Pernille Kronholm Rasmussen; Yinlei Bai; Xiulan Chen; Tanxi Cai; Jifeng Wang; Xiaojing Guo; Zhensheng Xie; Xiang Ding; Lili Niu; Nali Zhu; Xuefu You; Finn Kirpekar; Fuquan Yang
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

3.  High-Level Resistance to Colistin Mediated by Various Mutations in the crrB Gene among Carbapenemase-Producing Klebsiella pneumoniae.

Authors:  Aurélie Jayol; Patrice Nordmann; Adrian Brink; Maria-Virginia Villegas; Véronique Dubois; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Proteomic Investigation of the Signal Transduction Pathways Controlling Colistin Resistance in Klebsiella pneumoniae.

Authors:  Ching Hei Phoebe Cheung; Punyawee Dulyayangkul; Kate J Heesom; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

5.  Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.

Authors:  Miranda E Pitt; Minh Duc Cao; Mark S Butler; Soumya Ramu; Devika Ganesamoorthy; Mark A T Blaskovich; Lachlan J M Coin; Matthew A Cooper
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

6.  Missense Mutations in the CrrB Protein Mediate Odilorhabdin Derivative Resistance in Klebsiella pneumoniae.

Authors:  Lucile Pantel; Paulo Juarez; Marine Serri; Lilia Boucinha; Emilie Lessoud; Anne Lanois; Alain Givaudan; Emilie Racine; Maxime Gualtieri
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

Review 7.  Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB.

Authors:  Jiayuan Huang; Chen Li; Jiangning Song; Tony Velkov; Lushan Wang; Yan Zhu; Jian Li
Journal:  Future Microbiol       Date:  2020-04-06       Impact factor: 3.165

8.  Evolution of Colistin Resistance in the Klebsiella pneumoniae Complex Follows Multiple Evolutionary Trajectories with Variable Effects on Fitness and Virulence Characteristics.

Authors:  Axel B Janssen; Dennis J Doorduijn; Grant Mills; Malbert R C Rogers; Marc J M Bonten; Suzan H M Rooijakkers; Rob J L Willems; Jose A Bengoechea; Willem van Schaik
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

9.  Application of CRISPR/Cas9-Based Genome Editing in Studying the Mechanism of Pandrug Resistance in Klebsiella pneumoniae.

Authors:  Qiaoling Sun; Yu Wang; Ning Dong; Lingwei Shen; Hongwei Zhou; Yanyan Hu; Danxia Gu; Sheng Chen; Rong Zhang; Quanjiang Ji
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

Review 10.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.